Harvard-incubated Emulate aims to solve biotech drug failure woes by fusing microchips with human tissue

July 28, 2014 11:10 AM

15 0

When a promising biotech startup launches, it’s often years—and many millions of dollars invested—before anyone knows if their treatment is really going to work.

“Right now the amount of drugs that fail in the clinic is unbelievable,” said James Coon, chief executive of Cambridge startup Emulate Inc.

Also read: Ecuador judge orders jail for ex-minister in Petroecuador bribery case

Read more

To category page